Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$26,226,738
+$1,536,433 QoQ
Shares Held
21,866
-18.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#774
of 4,604 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. LLY ranks #1 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
|
286,435 | $6,897,354 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,226,738 | 21,866 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $24,690,305 | 26,844 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $22,841,250 | 21,254 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $16,055,809 | 21,043 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,836,931 | 20,316 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $17,278,036 | 20,920 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $19,953,140 | 22,522 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $20,974,937 | 23,167 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $20,618,273 | 26,503 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $14,060,030 | 24,120 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $20,319,627 | 37,830 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,199,103 | 40,938 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $13,909,883 | 40,504 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $12,943,419 | 35,380 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,871,107 | 27,435 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $8,859,584 | 27,325 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $7,052,433 | 24,627 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $11,710,899 | 42,397 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,166,477 | 31,017 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $7,458,940 | 32,498 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,511,937 | 29,504 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,982,806 | 29,512 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $4,365,849 | 29,495 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $5,675,866 | 34,571 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $3,735,590 | 26,929 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||